drugset / Trial / NCT03080922
High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML
Phase 1/2
Unknown
10 enrolled
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficiency of high dose allogeneic mismatched hematopoietic stem cells infusions after normal chemotherapy in patients with relapsed/refractory acute myeloid leukemia（AML）.
Timeline
- Start
- 2016-03
- Primary completion
- 2018-03
- Completion
- 2019-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | hematopoietic stem cell | Cell therapy | — | — |